Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Vitamin D receptor start codon polymorphism (FokI) and prostate cancer progression.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Jan 2003

Xu Yue, Shibata Atsuko, McNeal John E, Stamey Thomas A, Feldman David, Peehl Donna M

Abstract excerpt

Vitamin D plays an important role in cell growth and differentiation and is proposed to protect against cancer initiation and/or progression. The vitamin D receptor (VDR) has a thymine/cytosine (T/C) polymorphism located in the first of two potential start (ATG) codons that can be detected by a RFLP using the endonuclease FokI. The C variant, which lacks the first ATG, results in a shorter VDR and is referred to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Codon, Initiator
Share to Deoxyribonucleases, Type II Site-Specific

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Polymorphism, Genetic

Share to Prognosis

Share to Proportional Hazards Models

Share to Prostatectomy

Share to Prostatic Neoplasms

Share to Receptors, Calcitriol

Source

Identifiers

PMID: 12540499

Genes

VDR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Vitamin D receptor start codon polymorphism (FokI) and prostate cancer progression.PMID 12540499Read ↗

Association of vitamin D receptor <i>Fok</i>I polymorphism with prostate cancer risk, clinicopathological features and recurrence of prostate specific antigen after radical prostatectomySemantic proximity Read ↗

Risk of early-onset prostate cancer in relation to germ line polymorphisms of the vitamin D receptor.Semantic proximity Read ↗

The Fok1 vitamin D receptor gene polymorphism and 25(OH) D serum levels and prostate cancer among Jordanian men.Semantic proximity Read ↗

[Polymorphism of vitamin D receptor gene FokI and susceptibility of prostatic cancer: a meta-analysis].Semantic proximity Read ↗

Genetic polymorphisms of vitamin D receptor and the risk of prostate cancer: a meta-analysis.Semantic proximity Read ↗

Association of Vitamin D receptor Fok I polymorphism with the risk of prostate cancer: a meta-analysis.Semantic proximity Read ↗

Vitamin D receptor genotypes/haplotypes and prostate cancer risk.Semantic proximity Read ↗

[Association of single nucleotide polymorphism of vitamin D receptor gene start codon and the susceptibility to prostate cancer in the Han nationality in Hubei area].Semantic proximity Read ↗

Genetic variants in the vitamin d receptor are associated with advanced prostate cancer at diagnosis: findings from the prostate testing for cancer and treatment study and a systematic review.Semantic proximity Read ↗

Vitamin D receptor gene polymorphisms, insulin-like growth factors, and prostate cancer risk: a population-based case-control study in China.Semantic proximity Read ↗

Association of vitamin D receptor gene polymorphism and risk of prostate cancer in India.Semantic proximity Read ↗

Clinical and pathological significance of vitamin D receptor gene polymorphism for prostate cancer which is associated with a higher mortality in Japanese.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.